Pacer Advisors
JAZZ icon

Pacer Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Pacer Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.1M Sell
503,013
-144,071
-22% -$25.2M 0.27% 88
2025
Q4 		$110M Buy
647,084
+107,144
+20% +$16.4M 0.28% 76
2025
Q3 		$71.2M Sell
539,940
-194,639
-26% -$23.3M 0.18% 131
2025
Q2 		$78M Sell
734,579
-110,126
-13% -$12M 0.19% 111
2025
Q1 		$105M Sell
844,705
-1,369,775
-62% -$179M 0.25% 84
2024
Q4 		$273M Buy
2,214,480
+115,102
+5% +$13.6M 0.59% 41
2024
Q3 		$234M Buy
2,099,378
+278,465
+15% +$30.5M 0.49% 51
2024
Q2 		$194M Buy
1,820,913
+527,187
+41% +$58M 0.44% 53
2024
Q1 		$156M Buy
1,293,726
+270,020
+26% +$33.1M 0.36% 85
2023
Q4 		$126M Buy
1,023,706
+224,865
+28% +$28.1M 0.36% 76
2023
Q3 		$103M Buy
798,841
+114,552
+17% +$15.3M 0.4% 61
2023
Q2 		$84.8M Buy
684,289
+206,243
+43% +$27.7M 0.34% 64
2023
Q1 		$70M Buy
478,046
+137,586
+40% +$20.4M 0.3% 76
2022
Q4 		$54.2M Buy
340,460
+337,685
+12,169% +$49.5M 0.28% 70
2022
Q3 		$370K Buy
+2,775
New +$422K ﹤0.01% 1023
2022
Q1 		– Sell
-6,260
Closed -$798K – 2414
2021
Q4 		$798K Sell
6,260
-463
-7% -$60.8K 0.01% 1339
2021
Q3 		$875K Sell
6,723
-16,149
-71% -$2.44M 0.01% 931
2021
Q2 		$4.06M Buy
22,872
+16,567
+263% +$2.87M 0.06% 417
2021
Q1 		$1.04M Buy
6,305
+239
+4% +$39.3K 0.02% 759
2020
Q4 		$1M Buy
+6,066
New +$903K 0.02% 696

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Pacer Advisors's JAZZ Position: Q1 2026 in Review

Pacer Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 22% in Q1 2026, selling an estimated $25.2M and leaving 503,013 shares worth $95.1M. The position accounts for 0.27% of the portfolio, ranked #88.

Pacer Advisors first reported a position in JAZZ in Q4 2020 and has held it in 20 quarters since. The position peaked at $273M in Q4 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Pacer Advisors held 503,013 shares of Jazz Pharmaceuticals worth $95.1M as of Q1 2026.
  • Pacer Advisors sold 144,071 Jazz Pharmaceuticals shares in Q1 2026, an estimated $25.2M.
  • Jazz Pharmaceuticals made up 0.27% of Pacer Advisors's portfolio in Q1 2026, its #88 holding.
  • Pacer Advisors first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 20 quarters since.
  • Pacer Advisors's Jazz Pharmaceuticals position peaked at $273M in Q4 2024.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.